Up-regulation of both EGR1 and miR-152 inhibit the downstream target genes of miR-152, and ATG14, thus suppressing cisplatin resistance in ovarian cancer cells by preventing protective autophagy in ovarian cancer cells [44]. The gene discussed is ATG14; the disease is ovarian cancer.